OA
BSX icon

Operose Advisors’s Boston Scientific BSX Stock Holding History

Operose Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.4K Sell
1,672
-30
-2% -$1.63K 0.01% 269
2026
Q1 		$107K Buy
1,702
+30
+2% +$2.4K 0.02% 212
2025
Q4 		$159K Hold
1,672
– – 0.04% 174
2025
Q3 		$163K Buy
+1,672
New +$173K 0.04% 163
2024
Q4 		– Sell
-205
Closed -$17.2K – 456
2024
Q3 		$17.2K Hold
205
– – 0.01% 418
2024
Q2 		$15.8K Hold
205
– – 0.01% 382
2024
Q1 		$14K Hold
205
– – ﹤0.01% 436
2023
Q4 		$11.9K Sell
205
-855
-81% -$45.6K ﹤0.01% 440
2023
Q3 		$56K Buy
+1,060
New +$55.6K 0.02% 289

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Operose Advisors's BSX Position: Q2 2026 in Review

Operose Advisors reduced its Boston Scientific (BSX) stake by 1.8% in Q2 2026, selling an estimated $1.63K and leaving 1,672 shares worth $71.4K. The position accounts for 0.01% of the portfolio, ranked #269.

Operose Advisors first reported a position in BSX in Q3 2023 and has held it in 9 quarters since. The position peaked at $163K in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Operose Advisors held 1,672 shares of Boston Scientific worth $71.4K as of Q2 2026.
  • Operose Advisors sold 30 Boston Scientific shares in Q2 2026, an estimated $1.63K.
  • Boston Scientific made up 0.01% of Operose Advisors's portfolio in Q2 2026, its #269 holding.
  • Operose Advisors first reported a position in Boston Scientific in Q3 2023 and has held it in 9 quarters since.
  • Operose Advisors's Boston Scientific position peaked at $163K in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.